RxPack enters
pharma packaging sector
Coster & LINDAL team up to create aerosol pharmaceutical packaging firm
Newly-formed RxPack (pronounced R-x-Pack) will include
complementary product lines from LINDAL Group and
Coster Group for spray packaging solutions for pharmaceutical
applications. RxPack will offer pulmonary inhalation devices,
such as aerosol metered dose inhalers (MDIs) and nasal pumps,
as well as other aerosol and dispensing solutions for the regulated
and non-regulated pharmaceutical sectors.
RxPack’s packaging solutions will be supplemented with the
corresponding aerosol filling machinery for the pharmaceutical
sector. The new company will operate from LINDAL’s current
pharmaceutical facility in Oggiono, Italy. The site offers working
and production conditions, including the required cleanrooms
and laboratories, along with the opportunity to build further
pharmaceutical sector capabilities. RxPack will start its operations
with approximately 60 employees, all of whom have
previously worked in the pharmaceutical business. RxPack will
also hire additional industry experts to further strengthen the
organization.
Coster and LINDAL will each have an equal share in RxPack,
which is expected to commence business by the end of 2021,
after approval from relevant authorities.
Outside of RxPack, LINDAL and Coster are competitors in
various areas and will remain so. RxPack will therefore operate
as a stand-alone entity that is completely independent from the
two groups. To ensure this independence, RxPack will have a
fully autonomous organization with corresponding governance
and separate facilities. The facility in Oggiono will be exclusively
dedicated to RxPack. All other non-pharmaceutical activities at
this location will be relocated to other LINDAL facilities during
a managed transition period. Spray
May 2021 Spray 23
Coster and LINDAL will each have an equal
share in RxPack, which is expected to
commence business by the end of 2021...